Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AIG1P1 (Androgen induced 1 pseudogene 1) is a pseudogene found in Homo sapiens and listed in HUGO Gene Nomenclature Committee (HGNC:43926) and NCBI Gene (Gene ID: 106479028), without evidence of protein-coding function[1][5][7][9]. There are no reportable biological functions, associated disease roles, drug interactions, or use as a biomarker. Its locus is on chromosome 5. This pseudogene is distinct from AIG1 (androgen induced 1), which is a protein-coding gene; please note that AIG1P1 is not considered a receptor, enzyme, or other canonical therapeutic target[1][3][5][7][9]. The entry is only supported as a non-coding DNA segment, and not as an actionable molecule in drug discovery or biology. AIG1P1 is not a true drug target, receptor, enzyme, or transporter. It is a non-protein-coding pseudogene, and is thus not considered a valid therapeutic target. There is nothing to indicate its use in drug discovery, disease association, or experimental biology[1][3][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Androgen induced 1 pseudogene 1 (AIG1P1).